Cheng Hsin General Hospital

What Cheng Hsin General Hospital does

Cheng Hsin General Hospital (振興醫院) is a private, non-profit general hospital located in Beitou District, Taipei, Taiwan, founded in 1966. The hospital employs between 1,001 and 5,000 staff and is organized around multiple specialty departments, with its Heart Center serving as the flagship facility. It primarily serves cardiovascular disease patients, heart failure patients, and international medical patients from across the Asia-Pacific region, particularly those requiring advanced transcatheter valve procedures unavailable in their home countries. The hospital also operates secondary specialty lines in neurosurgery, aesthetic medicine, robotic surgery, and preventive health management.

Name

Cheng Hsin General Hospital

Legal name

Cheng Hsin General Hospital (振兴医疗财团法人 振兴医院)

Website

https://chghims.com.tw

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Cheng Hsin General Hospital is a Taipei-based, non-profit general hospital specializing in advanced cardiovascular care. It serves domestic patients through Taiwan's National Health Insurance and international patients via its Heart Center, which performs Southeast Asia's highest volume of transcatheter mitral valve replacements.

Ownership category

akta.pro rank

Product category

Tertiary Cardiac Care Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), General Medical and Surgical Hospitals (622110)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA)

akta.pro secondary industries

International/Medical Tourism Hospital Systems (HLAFAAAN), Cardiovascular / Cath Lab & Electrophysiology Centers (HLAFAIAI), Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK)

Keywords

• Cardiac care services
• Transcatheter valve replacement
• Heart failure treatment
• International medical services
• Telehealth consultations

Headquarters

HQ city

Taipei

HQ country

Taiwan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Services Revenue: Direct patient care services including outpatient consultations, emergency services, diagnostic procedures, and surgical interventions. Fees are charged per visit and procedure with different rates for outpatient (registration fee 500 NTD, consultation fee 1,500 NTD) and emergency services (registration fee 700 NTD, consultation fee 3,880 NTD).
2. International Medical Services: Specialized services for international patients without Taiwan National Health Insurance, including dedicated administrative support (3,000 NTD escort fee), second opinion consultations (200 USD), and assistance with medical visa applications, transportation, and accommodation arrangements.
3. Telehealth Consultations: Remote medical consultations for patients unable to visit Taiwan physically, charged at 200 USD per second opinion consultation.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Cheng Hsin General Hospital is a private non-profit tertiary hospital in Taipei, Taiwan providing advanced cardiovascular care anchored by its Heart Center that performs transcatheter valve replacement (TAVR, TMVR, valve-in-valve), coronary artery bypass grafting, heart transplantation, and a multidisciplinary heart failure care program. The hospital also delivers neurosurgery, robotic-assisted (Da Vinci) surgery, aesthetic medicine, minimally traumatic stapes surgery, and a Health Management Center for executive check-ups, alongside a dedicated Telehealth and International Medical Services Center that provides remote second opinion consultations and medical tourism facilitation for international patients.

Product overview

Cheng Hsin General Hospital is a Taiwan-based general hospital offering a comprehensive portfolio of medical services centered around its leading Heart Center, which provides advanced cardiovascular care including transcatheter valve procedures (TAVR, TMVR), cardiovascular surgery, and heart transplantation. The hospital operates multiple specialty departments including cardiology, neurosurgery, aesthetic medicine, and robotic surgery (Da Vinci system). It has established a Telehealth Center providing remote monitoring services for cardiac patients, and an International Medical Services Center offering medical tourism services including telehealth consultations and second opinions for international patients. The hospital has been designated as Asia's teaching center for transcatheter valve disease treatment by Edwards Lifesciences, and has developed innovative techniques including modified anterior mitral leaflet cutting for TMVR. The hospital also provides training programs for foreign medical staff and hosts international conferences including the annual Taipei Valve Summit.

Differentiator

Problem solved

Functional benefit

Brands

• Heart Center (心脏医学中心): Leading cardiac care center specializing in transcatheter valve procedures, heart transplantation, and cardiovascular surgery
• Telehealth and International Medical Services Center (远距暨国际医疗中心)
• Cheng Hsin Live
• Taipei Valve Summit

Products and services

• Heart Center (Cardiac Medicine Center) Comprehensive cardiac care center offering advanced cardiovascular treatments including TAVR, TMVR, heart transplantation, and integrated cardiovascular surgery and cardiology team-based care for patients with structural heart disease, coronary artery disease, and advanced heart failure.
• Cardiovascular Surgery Surgical department performing coronary artery bypass grafting (CABG), valve surgeries, vasoring connector aortic reconstruction, and complex cardiovascular procedures for adult cardiac patients.
• Cardiology Medical department focused on diagnosis and treatment of heart diseases including cardiac catheterization, percutaneous coronary intervention (PCI), transcatheter valve procedures, and heart rhythm disorder management.
• Health Management Center Preventive healthcare center providing health examinations, screenings, and wellness management programs including executive check-ups for individual consumers seeking preventive care and early disease detection.
• Telehealth Center Remote healthcare services center providing telehealth consultations, remote ECG monitoring, blood pressure and blood glucose tracking, and remote pacemaker monitoring for post-operative and chronic disease patients, serving both domestic and international patients since 2006.
• Neurosurgery Brain and nervous system surgery department offering precise brain tumor surgeries, cerebrovascular surgeries, and spinal procedures for patients with neurological conditions.
• Minimally Traumatic Stapes Surgery Minimally invasive stapes surgery for patients with otosclerosis and conductive hearing loss, providing hearing restoration with reduced surgical trauma compared to conventional approaches.
• Da Vinci Robotic Surgery Robotic-assisted surgical system used for minimally invasive procedures across urology, gynecology, and general surgery specialties including complex cases such as large fibroid tumor removal with uterine preservation.
• Department of Aesthetic Medicine Cosmetic and aesthetic medical services including facial procedures, body contouring, laser treatments, and injectables such as botulinum toxin and dermal fillers, with SNQ-certified severe ptosis surgery capability.
• Telehealth Consultation & Second Opinion Service International medical service providing remote medical consultations and second opinions at 200 USD per consultation for international patients unable to visit Taiwan in person; includes video consultation and medical document review with specialist interpretation.
• International Medical Services Comprehensive end-to-end services for international patients including medical visa assistance, appointment scheduling, interpreter services, dedicated escort (3,000 NTD administrative fee), airport pickup, and accommodation arrangement to enable medical tourism from over 30 countries.
• Transcatheter Aortic Valve Replacement (TAVR) Minimally invasive catheter-based procedure for aortic valve replacement enabling safe and rapid recovery for elderly patients and those with multiple comorbidities who are unsuitable for open-heart surgery; performed over 1,000 times at the hospital.
• Transcatheter Mitral Valve Replacement (TMVR) Catheter-based mitral valve replacement procedure with highest single-center volume in Southeast Asia (over 100 cases); enables treatment for patients unsuitable for repeat open-heart surgery, including those with previously surgically repaired mitral valves.
• Heart Failure Care Program Comprehensive multidisciplinary heart failure management program integrating cardiovascular surgeons, cardiologists, heart transplant specialists, rehabilitation therapists, pharmacists, dietitians, psychologists, and nurses for chronic heart failure patients across acute care, post-acute transitions, device therapy, and heart transplantation.
• Training Program for Foreign Medical Staff International education and training program for foreign physicians and medical staff in transcatheter valve procedures, hosted as Asia's designated Edwards Lifesciences teaching center to build international clinical capability and referral relationships.

Quantifiable outcome

• TMVR success rate improved from 80% internationally to 91% using proprietary technique
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Nine partnerships are on record, tiered flagship, core and minor.

• Edwards LifesciencesflagshipStrategic or Co-development Partner · 1 January 2024American valve company that designated Cheng Hsin General Hospital as Asia's teaching center for transcatheter valve disease treatment. The hospital trains physicians from Malaysia, Thailand, Vietnam, and other countries in transcatheter valve procedures using Edwards Lifesciences products.
• PCR (PCR-CIT China Chengdu Valves)coreStrategic or Co-development Partner · 4 November 2023Vice Superintendent Yin Wei Hsian serves as PCR Faculty, presenting at EuroPCR and PCR TAVI Seminar. The hospital participated in PCR TAVI Seminar in Cebu, Philippines in November 2025, sharing clinical experience with Asia-Pacific experts.
• Panzhihua College Affiliated Hospital (攀枝花学院附属医院)coreStrategic or Co-development Partner · 30 August 2019Signed cooperation agreement on August 30, 2019 for medical collaboration including hospital management systems, talent training, clinical expertise, and medical quality improvement. Vice Superintendent Yin Wei Hsian represented the hospital in signing.
• Xiamen University Affiliated Cardiovascular Hospital (厦门大学附属心血管病医院)coreStrategic or Co-development PartnerParticipated in CHENG HSIN Live 2023 conference with live surgery demonstrations. President Wang Yan and cardiac team attended and performed joint surgical demonstrations during the international conference.
• Northwest University (Seattle, USA) - Buntain College of NursingcoreStrategic or Co-development PartnerOngoing cross-cultural nursing exchange program since 2001 (19+ years). Students from the nursing program visit for month-long clinical practice at the hospital. Multiple visits per year with joint activities including clinical observations in various departments.
• Taiwan Healthcare Management AssociationminorStrategic or Co-development PartnerOrganizer of Taiwan Health Care Quality Management Competition where the hospital won Gold Award in 2023 for telehealth ECG monitoring project.
• Qin Xiang Yuan Health Industry Group (亲祥源健康产业集团, Shandong, China)minorStrategic or Co-development PartnerSigned agreement to establish telehealth consultation center partnership in October 2021, enabling remote medical consultations for mainland China patients.
• American Heart AssociationflagshipStrategic or Co-development PartnerParticipated in Get-With-The-Guidelines ASIA program since 2022. Achieved GOLD PLUS Achievement Award by meeting 7 of 8 quality indicators. Joint quality improvement initiative with monthly meetings, data collection, and progress tracking.
• Taiwan Joint Commission on Hospital Accreditation (医策会)coreStrategic or Co-development PartnerAccreditation body that certified the hospital's Heart Failure Care Program in April 2024. Recognized for comprehensive multidisciplinary approach to heart failure management.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Samsung Medical Center: Leading Korean tertiary hospital with a strong cardiovascular center. Competes for medical tourism and complex cardiac cases in the wider Asia-Pacific region.
• National Taiwan University Hospital: Taiwan's leading academic medical center with a strong cardiovascular program and large patient volumes. Most direct domestic peer, competing for complex cardiac cases and international patients in Taipei.
• Taipei Veterans General Hospital: Major Taiwanese tertiary hospital with prominent cardiology and cardiac surgery departments. Competes directly with Cheng Hsin for complex cardiac referrals, TAVR cases, and international medical travelers.
• Asan Medical Center: One of Korea's largest hospitals with a renowned Heart Institute, performing high volumes of TAVR and structural heart procedures. Comparable regional specialty cardiac care competitor for international patients across Asia.
• Asian Heart Institute: India-based specialty cardiac hospital focused on cardiac surgery and interventional cardiology. Comparable business model centered on complex cardiac procedures for domestic and international patients.
• Fuwai Hospital (National Center for Cardiovascular Diseases): China's premier cardiovascular specialty hospital with massive TAVR and structural heart volumes. Competes for cross-strait and Southeast Asian medical tourism demand.

Regional players

• Bumrungrad International Hospital: Thailand-based international hospital with a strong medical tourism franchise and cardiac care services. Competitor for Southeast Asian and international medical travelers in cardiology.
• Mount Elizabeth Hospital (Singapore): Singapore-based private hospital with advanced cardiac surgery and structural heart programs. Competes for affluent Southeast Asian patients seeking complex cardiac care.

Others

• Edwards Lifesciences: Strategic device partner and transcatheter heart valve manufacturer. Designated Cheng Hsin as Asia's teaching center, making it both a critical partner and an adjacent player in the structural heart ecosystem.

Broad incumbents

• Cleveland Clinic: Globally renowned cardiovascular center with very high TAVR/structural heart volumes. Represents the global benchmark for cardiac care quality and international patient services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@Cheng-Hsin-heart-center/streams
• Facebookfacebook.com/Cheng-Hsin-General-Hospital-61567274362218
• LinkedInlinkedin.com/company/cheng-hsin-general-hospital

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cheng Hsin General Hospital